(COP) ConocoPhillips - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US20825C1045
Stock: Crude Oil, Natural Gas, LNG, Bitumen
Total Rating 59
Risk 87
Buy Signal 0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 25.4% |
| Relative Tail Risk | -1.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 18.26 |
| Character TTM | |
|---|---|
| Beta | 0.455 |
| Beta Downside | 0.746 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.52% |
| CAGR/Max DD | 0.35 |
EPS (Earnings per Share)
Revenue
Description: COP ConocoPhillips March 04, 2026
ConocoPhillips (COP) is an independent exploration and production (E&P) company. E&P companies focus on finding and extracting hydrocarbons, rather than refining or retailing them.
The companys operations span crude oil, natural gas, LNG, and natural gas liquids across five geographic segments: Alaska, Lower 48 (contiguous US), Canada, Europe/Middle East/North Africa, and Asia Pacific. This diversified portfolio includes unconventional plays, conventional assets, and oil sands.
ConocoPhillips has a global presence, operating in numerous countries including the United States, Canada, the UK, and China. Consider exploring ValueRay for further in-depth analysis of COPs operational efficiency and financial performance.
Headlines to watch out for
- Global crude oil prices dictate exploration and production revenue
- Natural gas demand and pricing impact LNG profitability
- Regulatory changes in carbon emissions increase operating costs
- Geopolitical instability threatens international production and transport
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 7.97b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 7.23 > 1.0 |
| NWC/Revenue: 6.06% < 20% (prev 6.45%; Δ -0.39% < -1%) |
| CFO/TA 0.16 > 3% & CFO 19.80b > Net Income 7.97b |
| Net Debt (16.95b) to EBITDA (25.02b): 0.68 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.20b) vs 12m ago 1.33% < -2% |
| Gross Margin: 24.82% > 18% (prev 0.29%; Δ 2.45k% > 0.5%) |
| Asset Turnover: 48.04% > 50% (prev 44.48%; Δ 3.56% > 0%) |
| Interest Coverage Ratio: 11.73 > 6 (EBITDA TTM 25.02b / Interest Expense TTM 1.14b) |
Altman Z'' 3.92
| A: 0.03 (Total Current Assets 15.53b - Total Current Liabilities 11.97b) / Total Assets 121.94b |
| B: 0.56 (Retained Earnings 68.86b / Total Assets 121.94b) |
| C: 0.11 (EBIT TTM 13.36b / Avg Total Assets 122.36b) |
| D: 1.10 (Book Value of Equity 62.98b / Total Liabilities 57.45b) |
| Altman-Z'' Score: 3.92 = AA |
Beneish M -2.99
| DSRI: 0.81 (Receivables 5.81b/6.70b, Revenue 58.78b/54.61b) |
| GMI: 1.18 (GM 24.82% / 29.35%) |
| AQI: 1.13 (AQ_t 0.11 / AQ_t-1 0.10) |
| SGI: 1.08 (Revenue 58.78b / 54.61b) |
| TATA: -0.10 (NI 7.97b - CFO 19.80b) / TA 121.94b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of COP shares?
As of March 24, 2026, the stock is trading at USD 127.19 with a total of 9,440,332 shares traded.
Over the past week, the price has changed by +4.84%, over one month by +15.75%, over three months by +38.23% and over the past year by +28.73%.
Over the past week, the price has changed by +4.84%, over one month by +15.75%, over three months by +38.23% and over the past year by +28.73%.
Is COP a buy, sell or hold?
ConocoPhillips has received a consensus analysts rating of 4.37.
Therefore, it is recommended to buy COP.
- StrongBuy: 14
- Buy: 13
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the COP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 123.7 | -2.8% |
| Analysts Target Price | 123.7 | -2.8% |
COP Fundamental Data Overview March 21, 2026
P/E Trailing = 19.8313
P/E Forward = 31.0559
P/S = 2.5737
P/B = 2.3887
P/EG = 4.1945
Revenue TTM = 58.78b USD
EBIT TTM = 13.36b USD
EBITDA TTM = 25.02b USD
Long Term Debt = 22.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 23.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.95b USD (from netDebt column, last quarter)
Enterprise Value = 172.09b USD (155.14b + Debt 23.44b - CCE 6.50b)
Interest Coverage Ratio = 11.73 (Ebit TTM 13.36b / Interest Expense TTM 1.14b)
EV/FCF = 10.26x (Enterprise Value 172.09b / FCF TTM 16.77b)
FCF Yield = 9.75% (FCF TTM 16.77b / Enterprise Value 172.09b)
FCF Margin = 28.54% (FCF TTM 16.77b / Revenue TTM 58.78b)
Net Margin = 13.56% (Net Income TTM 7.97b / Revenue TTM 58.78b)
Gross Margin = 24.82% ((Revenue TTM 58.78b - Cost of Revenue TTM 44.19b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 24.12%)
Tobins Q-Ratio = 1.41 (Enterprise Value 172.09b / Total Assets 121.94b)
Interest Expense / Debt = 1.24% (Interest Expense 290.0m / Debt 23.44b)
Taxrate = 35.77% (803.0m / 2.25b)
NOPAT = 8.58b (EBIT 13.36b * (1 - 35.77%))
Current Ratio = 1.30 (Total Current Assets 15.53b / Total Current Liabilities 11.97b)
Debt / Equity = 0.36 (Debt 23.44b / totalStockholderEquity, last quarter 64.49b)
Debt / EBITDA = 0.68 (Net Debt 16.95b / EBITDA 25.02b)
Debt / FCF = 1.01 (Net Debt 16.95b / FCF TTM 16.77b)
Total Stockholder Equity = 65.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.52% (Net Income 7.97b / Total Assets 121.94b)
RoE = 12.25% (Net Income TTM 7.97b / Total Stockholder Equity 65.06b)
RoCE = 15.27% (EBIT 13.36b / Capital Employed (Equity 65.06b + L.T.Debt 22.42b))
RoIC = 9.71% (NOPAT 8.58b / Invested Capital 88.41b)
WACC = 6.69% (E(155.14b)/V(178.58b) * Re(7.58%) + D(23.44b)/V(178.58b) * Rd(1.24%) * (1-Tc(0.36)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Terminal Value 82.30% ; FCFF base≈13.27b ; Y1≈12.02b ; Y5≈10.48b
[DCF] Fair Price = 196.5 (EV 257.10b - Net Debt 16.95b = Equity 240.16b / Shares 1.22b; r=6.69% [WACC]; 5y FCF grow -11.66% → 3.0% )
EPS Correlation: -67.64 | EPS CAGR: -26.70% | SUE: -0.81 | # QB: 0
Revenue Correlation: -62.27 | Revenue CAGR: -7.97% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.41 | Chg7d=+0.196 | Chg30d=+0.343 | Revisions Net=+5 | Analysts=16
EPS current Year (2026-12-31): EPS=5.53 | Chg7d=+0.329 | Chg30d=+0.943 | Revisions Net=+5 | Growth EPS=-10.3% | Growth Revenue=-5.1%
EPS next Year (2027-12-31): EPS=6.76 | Chg7d=-0.008 | Chg30d=-0.097 | Revisions Net=-1 | Growth EPS=+22.4% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: +1.00 (5 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 7.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = -5.8% (Analyst -2.9% - Implied 2.9%)
P/E Forward = 31.0559
P/S = 2.5737
P/B = 2.3887
P/EG = 4.1945
Revenue TTM = 58.78b USD
EBIT TTM = 13.36b USD
EBITDA TTM = 25.02b USD
Long Term Debt = 22.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 23.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.95b USD (from netDebt column, last quarter)
Enterprise Value = 172.09b USD (155.14b + Debt 23.44b - CCE 6.50b)
Interest Coverage Ratio = 11.73 (Ebit TTM 13.36b / Interest Expense TTM 1.14b)
EV/FCF = 10.26x (Enterprise Value 172.09b / FCF TTM 16.77b)
FCF Yield = 9.75% (FCF TTM 16.77b / Enterprise Value 172.09b)
FCF Margin = 28.54% (FCF TTM 16.77b / Revenue TTM 58.78b)
Net Margin = 13.56% (Net Income TTM 7.97b / Revenue TTM 58.78b)
Gross Margin = 24.82% ((Revenue TTM 58.78b - Cost of Revenue TTM 44.19b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 24.12%)
Tobins Q-Ratio = 1.41 (Enterprise Value 172.09b / Total Assets 121.94b)
Interest Expense / Debt = 1.24% (Interest Expense 290.0m / Debt 23.44b)
Taxrate = 35.77% (803.0m / 2.25b)
NOPAT = 8.58b (EBIT 13.36b * (1 - 35.77%))
Current Ratio = 1.30 (Total Current Assets 15.53b / Total Current Liabilities 11.97b)
Debt / Equity = 0.36 (Debt 23.44b / totalStockholderEquity, last quarter 64.49b)
Debt / EBITDA = 0.68 (Net Debt 16.95b / EBITDA 25.02b)
Debt / FCF = 1.01 (Net Debt 16.95b / FCF TTM 16.77b)
Total Stockholder Equity = 65.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.52% (Net Income 7.97b / Total Assets 121.94b)
RoE = 12.25% (Net Income TTM 7.97b / Total Stockholder Equity 65.06b)
RoCE = 15.27% (EBIT 13.36b / Capital Employed (Equity 65.06b + L.T.Debt 22.42b))
RoIC = 9.71% (NOPAT 8.58b / Invested Capital 88.41b)
WACC = 6.69% (E(155.14b)/V(178.58b) * Re(7.58%) + D(23.44b)/V(178.58b) * Rd(1.24%) * (1-Tc(0.36)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Terminal Value 82.30% ; FCFF base≈13.27b ; Y1≈12.02b ; Y5≈10.48b
[DCF] Fair Price = 196.5 (EV 257.10b - Net Debt 16.95b = Equity 240.16b / Shares 1.22b; r=6.69% [WACC]; 5y FCF grow -11.66% → 3.0% )
EPS Correlation: -67.64 | EPS CAGR: -26.70% | SUE: -0.81 | # QB: 0
Revenue Correlation: -62.27 | Revenue CAGR: -7.97% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.41 | Chg7d=+0.196 | Chg30d=+0.343 | Revisions Net=+5 | Analysts=16
EPS current Year (2026-12-31): EPS=5.53 | Chg7d=+0.329 | Chg30d=+0.943 | Revisions Net=+5 | Growth EPS=-10.3% | Growth Revenue=-5.1%
EPS next Year (2027-12-31): EPS=6.76 | Chg7d=-0.008 | Chg30d=-0.097 | Revisions Net=-1 | Growth EPS=+22.4% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: +1.00 (5 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 7.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = -5.8% (Analyst -2.9% - Implied 2.9%)